Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
您的位置：
